corneal staining

Topical IL-1 receptor blocker manages signs, symptoms of dry eyeA therapeutic in development blocks interleukin-1—a major player in the initiation and maintenance of the inflammatory response—and may help patients with moderate to severe dry eye disease.
Clinical implications of corneal hyperfluorescenceOtolaryngologists (ENTs) have it easy. They can instruct their patients not to stick anything in their ears that is smaller than their elbows, and not only is it sound medical advice, but it has a fairly high rate of compliance. Eyecare professionals (ECPs) who fit contact lenses, on the other hand, have a more difficult hill to climb because we purposely put materials in our patients’ eyes, an impossible feat without biocompatible products.